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Introduction
Werner syndrome (WS) is a heavily studied human premature
ageing disorder. It is autosomal recessive and characterized by
short stature, premature onset of cataracts, skin atrophy and
ulceration, hair greying, and age-related diseases such as type-
II diabetes mellitus, osteoporosis, soft-tissue calcification and
atherosclerosis (Salk, 1982; Epstein et al., 1996; Martin et al.,
1999). WS is also associated with an increase in neoplasms of
mesenchymal origin (Goto et al., 1996). With the exception of
central nervous system degeneration, this disease provides a
convincing mimic of the normal ageing phenotype (Brown et
al., 1985) and is thus an important model disease.
The underlying genetic defect in WS is a recessive loss-of-
function mutation in the WRN gene. WRN encodes a member of
the RecQ helicase family (Yu et al., 1996) which, unlike other
members of the RecQ family, also shows 3¢ to 5¢ exonuclease
activity (Huang et al., 1998). WRNp is a nuclear protein that is
found predominantly in the nucleoli but that relocates to
replication foci at S phase of the cell cycle, and to sites of DNA
damage in response to DNA-damaging agents such as 4-
nitroquinoline 1-oxide (Gray et al., 1998; Marciniak et al., 1998;
Shiratori et al., 1999). It interacts with a range of other proteins,
including topoisomerase I, Ku 86/70, replication protein A, p53
and DNA polymerase d (Shen and Loeb, 2001). WRNp has been
implicated in DNA replication, transcription, DNA recombination
and DNA repair (Bohr et al., 2002). Although WS cells do show
a chromosome instability phenotype (Hoehn et al., 1975; Salk et
al., 1981; Fukuchi et al., 1989), WS is not a dramatic DNA-repair-
defect syndrome when compared with diseases such as xeroderma
pigmentosum. Although WRNp does play a role in DNA repair,
loss of expression has only a mild impact on the ability of WS
cells to undergo DNA repair (Bohr et al., 2001).
Normal human fibroblasts have a finite capacity to divide,
after which they enter a state of permanent cell-cycle arrest
termed replicative senescence (also known as mortality stage
1 or M1). Cultures of such cells cease to expand as a result of
a progressive decline in the growth fraction. The kinetics of
this process have long been recognized to be consistent with
the operation of one or more molecular mechanisms capable
of acting as a cell division ‘counting’ system. In human dermal
fibroblasts, it is now known that this counting mechanism is
based on the activation of p53 as a result of the progressive
erosion of chromosomal telomeres (Bodnar et al., 1998; Vaziri
and Benchimol, 1998; Wright and Shay, 2002).
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Werner-syndrome fibroblasts have a reduced in vitro life
span before entering replicative senescence. Although this
has been thought to be causal in the accelerated ageing of
this disease, controversy remains as to whether Werner
syndrome is showing the acceleration of a normal cellular
ageing mechanism or the occurrence of a novel Werner-
syndrome-specific process. Here, we analyse the signalling
pathways responsible for senescence in Werner-syndrome
fibroblasts. Cultured Werner-syndrome (AG05229)
fibroblasts senesced after ~20 population doublings with
most of the cells having a 2N content of DNA. This was
associated with hypophosphorylated pRb and high levels of
p16Ink4a and p21Waf1. Senescent AG05229 cells re-entered
the cell cycle following microinjection of a p53-neutralizing
antibody. Similarly, production of the human papilloma
virus 16 E6 oncoprotein in presenescent AG05229 cells
resulted in senescence being bypassed and extended
cellular life span. Werner-syndrome fibroblasts expressing
E6 did not proliferate indefinitely but reached a second
proliferative lifespan barrier, termed Mint, that could be
bypassed by forced production of telomerase in post-M1
E6-producing cells. The conclusions from these studies
are that: (1) replicative senescence in Werner-syndrome
fibroblasts is a telomere-induced p53-dependent event; and
(2) the intermediate lifespan barrier Mint is also a telomere-
induced event, although it appears to be independent of
p53. Werner-syndrome fibroblasts resemble normal human
fibroblasts for both these proliferative lifespan barriers,
with the strong similarity between the signalling pathway
linking telomeres to cell-cycle arrest in Werner-syndrome
and normal fibroblasts providing further support for the
defect in Werner syndrome causing the acceleration of a
normal ageing mechanism.
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WS fibroblast cultures display a dramatic reduction in
replicative life span (Martin et al., 1970) owing to an increased
rate of decline in the culture growth fraction compared with
normal controls (Faragher et al., 1993). Loss of the WRN
helicase has the potential to produce many abortive DNA
replication events that could trigger premature cell-cycle exit
without involving telomeric loss. Thus, an important but
unresolved question is the extent to which the rapid replicative
senescence seen in WS fibroblasts results from an acceleration
of normal senescence mechanisms and to what extent (if any)
it results from chromosomal instability and replication-fork
stalling as a result of mutations in WRN.
Although several groups have shown that telomere
shortening acts as a primary driver of senescence in WS
fibroblasts (Ouellette et al., 2000; Wyllie et al., 2000; Choi et
al., 2001), these studies did not address in detail the signalling
pathway downstream of telomere erosion in WS cells.
Replicative senescence is associated, in the case of dermal
fibroblasts from newborns or adults, with activation of p53 as
a transcriptional transactivator (Itahana et al., 2001), as shown
by the induction of p53-dependent transcripts such as the
cyclin-dependent kinase inhibitor p21Waf1 or p53-dependent
reporter constructs in senescent fibroblasts (Bond et al., 1994;
Bond et al.,1995; Bond et al., 1996; Webley et al., 2000).
Furthermore, abrogation of p53 function using dominant-
negative p53 alleles, microinjection of anti-p53 antibodies or
viral oncoproteins such as human papilloma virus 16 (HPV16)
E6 leads to a bypassing of senescence and extension of lifespan
(Bond et al., 1994; Bond et al., 1999; Gire and Wynford-
Thomas, 1998).
Accordingly, in the present study, we address whether
replicative senescence in WS fibroblasts shows features
consistent with an acceleration of the mechanism of senescence
that is seen in normal dermal fibroblasts. Two complementary
experimental approaches were undertaken: (1) observational
studies of key cell-cycle proteins (including those normally
involved in the p53 response); and (2) direct experimental
abrogation of p53 function using two independent methods.
Materials and Methods
Cell culture
HCA2 human diploid fibroblasts were provided by Jim Smith (Baylor
College of Medicine, Houston, Texas). WS cell strain AG05229 was
obtained from the Coriell NIA Aging Cell Culture Repository
(Camden, New Jersey). All cells were grown in Dulbecco’s modified
Eagle medium (Life Technologies) supplemented with 10% foetal
calf serum (Imperial Labs). Determination of in vitro life span and
passage protocols were as described by Bond et al. (Bond et al.,
1996).
Retroviral gene transfer
Amphotropic retrovirus vectors expressing the HPV16 E6
oncoprotein from a pLXSN construct, packaged in PA317 cells
(Halbert et al., 1991), were kindly provided by Denise Galloway
(University of Washington, Seattle, WA). pBABEhTERT (Wyllie et
al., 2000) is an amphotropic retrovirus expressing hTERT, the
catalytic protein subunit of human telomerase, constructed by cloning
the EcoRI insert of pGRN121 (Nakamura et al., 1997) into
pBABEpuro (Morgenstern and Land, 1990). For control infections,
pBABEneo, or pBABEpuro vectors, packaged in y CRIP cells, were
used (Wyllie et al., 2000).
Gene transfer was carried out as described previously (Bond et al.,
1994). Two days later, fibroblast cultures were passed into medium
containing G418 (0.4 mg ml–1), or puromycin (2.5 m g ml–1), at serial
dilutions of 1:5, 1:10, 1:100 and 1:250, and observed for colony
development. For each gene transfer, the retroviral infections were
done twice.
BrdU incorporation assays
Cells were labelled by incubation in 10 m M bromodeoxyuridine
(BrdU) for 1 hour, with incorporation detected by immunoperoxidase
(Bond et al., 1996). The proportion of BrdU-positive cells was
assessed in a total count of 500 cells.
Detection of senescence-associated b -galactosidase activity
Endogenous mammalian senescence-associated b -galactosidase
activity (SAb -gal) was assessed histochemically (Dimri et al., 1996;
Bond et al., 1999). The proportion of b -galactosidase-positive cells
was assessed in a total count of 500 cells.
Apoptosis (TUNEL) assays
Cytospin preparations of trypsinized cultures were prepared, treated
and incubated with terminal deoxynucleotidyl transferase (Promega)
and biotin-16-dUTP (Boehringer Mannheim) as described in (Bond
et al., 1999). Sites of biotin-16-dUTP localization were visualized by
using the mouse-specific avidin-biotin-peroxidase (ABC) system
(Vector Labs) (Bond et al., 1999). After haematoxylin counterstaining,
the proportion of apoptotic (brown) cells was assessed in samples of
500 cells.
Immunocytochemistry
For p21Waf1, cells on coverslips were fixed and pre-treated as
described (Bond et al., 1999). p21Waf1 was detected by incubation for
1 hour in a 1:500 dilution of an anti-p21Waf1 mouse monoclonal
antibody (6B6; Becton Dickinson), followed by a 1:100 dilution of
biotinylated anti-mouse antibodies using the ABC kit (Vector Labs).
The proportion of p21Waf1-positive cells was assessed in a total count
of 500 cells.
Immunoblotting
Protein samples were prepared, separated on 12% sodium-dodecyl-
sulphate/polyacrylamide electrophoresis gels (for pRb, a 7.5% gel was
used), electroblotted to Immobilon-P polyvinylidene difluoride
membrane (Millipore) and antibodies applied as described by Bond
et al. (Bond et al., 1999). The antibodies used were: mouse
monoclonal anti-p21Waf1 (6B6; Becton Dickinson); mouse
monoclonal anti-p16Ink4a (DCS50; Oncogene Research Products);
mouse monoclonal anti-p27Kip1 (C20; Transduction Laboratories);
mouse monoclonal anti-p53 (DO-1; Calbiochem); mouse anti-pRb
(C3-245; Becton Dickinson). A chemiluminescence kit (Amersham)
was used for visualization using goat anti-mouse secondary
antibodies. After visualization, blots were washed three times for 10
minutes in 0.1 M glycine (pH 2.5), once in 1 M Tris (pH 8.0) for 5
minutes, and then in PBS for 30 minutes, before reuse. After use, the
filter was stained with India ink.
Densitometric quantification analysis
Quantification of the specific signal and the amount of protein loaded
for the immunoblot (Fig. 2) was performed using a Bio-Rad imaging
densitometer with Molecular Analyst software. When normalized
based on protein loading, the relative amounts of p21Waf1 are 1.0 and
1.17 (arbitrary units) for cycling WS cells and WS cells at M1,
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respectively. WS cells at M1 have ~2.4 times more total protein per
cell than cycling WS cells (not shown), a figure similar to that seen
for IMR90 cells (Sherwood et al., 1988). Thus, taking into account
both the higher relative amount of p21Waf1 determined from Fig. 2
(1.17 times) and the increased amount of total protein per cell (2.4
times), WS cells at M1 have ~2.7 times as much p21Waf1 per cell than
cycling WS cells.
Microinjection of anti-p53 antibodies
Late-passage AG05229 cells were microinjected using an Eppendorf
system as described previously (Bond et al., 1996). Mouse
monoclonal antibody DO-1 (isotype IgG2a k ; Oncogene Research) or
control mouse IgG (Sigma) was injected at a concentration of 2 mg
ml–1 in PBS. Rabbit IgG (12 mg ml–1) (Sigma) was co-injected.
Following injection, cells were incubated in fresh medium for 48
hours and then incubated in 20 m M BrdU for 4 hours. Cells were
fixed as described above and BrdU incorporation was detected by
incubation in a 1:100 dilution of anti-BrdU (isotype IgG1 k ) (Dako)
with DNAase I (25 U ml–1) for 2 hours at 37°C, followed by
incubation for 1 hour at room temperature in a 1:50 dilution of
fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgG1-
isotype specific (Southern Biotechnology Associates). The isotype-
specific FITC-IgG1 is used to avoid a cross-reaction with
microinjected DO-1. Microinjected cells were detected using a
1:800 dilution of goat anti-rabbit-Texas Red conjugate (Southern
Biotechnology Associates). Nuclei were visualized by staining with
0.5 m g ml–1 4 ¢ -6-diamidino-2-phenylindole (DAPI) for 5 minutes
at room temperature, and the cells were mounted in 90% glycerol-
PBS. All antibody dilutions were in 1% bovine serum albumin in
PBS.
Cell-cycle analysis
Cells were washed twice with PBS prior to trypsinization. All cell-
culture media and PBS washes were collected with trypsinized cells
and spun down for 10 minutes at 300 g. Cell pellets were adjusted to
1 ml (3-6 · 105 cells ml–1). 125 m l of 0.4 mg ml–1 ethidium bromide
and 1% Triton X-100 was added, followed by 50 m l ribonuclease A
(10 mg ml–1). Samples were vortexed, incubated at room temperature
for 10 minutes and then immediately analysed by flow cytometry
(Smith et al., 1999). Direct observation of cell suspensions indicated
minimal doublet formation. Cell samples were analysed using a
FACScan flow cytometer (Becton Dickinson Immunocytometry
Systems). Histograms of cell numbers versus FL2-H (pulse height)
provided a measure of the DNA content of the cells.
Results
Growth characteristics of WS AG05229 fibroblasts
WS AG05229 fibroblasts at a population-doubling (PD) level
of 12 were passaged every 3-4 days until the cells entered
replicative senescence (M1), indicated by accumulation of
cells with a large irregular morphology (Fig. 1E), a BrdU
labelling index (LI) of 1.8±0.6%, a high level of SA b -gal
activity (95±1%) (Fig. 1G) and a low rate of cell death (<1%)
as determined by TUNEL assay (Fig. 1H). At this point, the
cells had undergone a total of 20.5 PDs since explantation, so
AG05229 has the reduced replicative potential reported for
these cells (Choi et al., 2001) that is typical of WS fibroblasts
in culture (Martin et al., 1970; Faragher et al., 1993).
Most of the AG05229 cells at M1 (>77%) were arrested
Fig. 1. (A-H) Immunocytochemical analysis of AG05229 cells.
(A-D) Cycling cells. (E-H) Cells at M1. The assays are: PC, phase
contrast; p21, immunocytochemical detection of p21Waf1; SAb gal,
histochemical assessment of SAb -gal activity; TUNEL, assay for
apoptosis. All cells except PC are counterstained with haematoxylin.
Cell-based assays were done in triplicate. (I,J) FACS analysis
histograms of cell number versus FL2-H for AG05229 and HCA2
cells at M1 (pulse height is a measure of DNA content). White bar,
100 m m (A,E); black bar, 100 m m (B-D,F-H).
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with a 2N DNA content as assessed by fluorescence-activated
cell sorting (FACS) analysis (Fig. 1I), which is consistent with
G1 arrest. However, a significant proportion (~20%) had
higher levels, reflecting G2 arrest and/or G1 tetraploid cells.
The same overall pattern was seen with control HCA2 cells
(Fig. 1J) and has been reported for IMR90 cells (Sherwood et
al., 1988).
Cycling AG05229 cells showed moderate levels of the
cyclin-dependent kinase inhibitor (CdkI) p21Waf1 in 22.5±1.8%
of the nuclei by immunocytochemistry (Fig. 1B). This
increased to 91.2±1.3% of the nuclei by the time the cells
reached M1 (Fig. 1F). Although, when analysed by
immunoblot using anti-p21Waf1 antibodies, cycling and M1
AG05229 cells appeared to have similar levels of p21Waf1 (Fig.
2), once quantified on a per-cell basis (see Materials and
Methods) to take into account the observation that cells at M1
have approximately twice the protein of cycling cells
(Sherwood et al., 1988), it is clear that there has been a
significant increase in the level of p21Waf1 as WS cells reach
M1. The presence of cycling cells in the young AG05229
population was indicated by their small size (Fig. 1A), a BrdU
LI of 29.5±2%, low levels of SA b -gal activity (6±1.1%) (Fig.
1C) and the presence of low but detectable levels of
hyperphosphorylated pRb (Fig. 2).
We have also examined the levels of two other CdkIs in
AG05229 cells. The CdkI p16Ink4a was present at almost
undetectable levels in cycling AG05229 cells (Fig. 2) and
showed a large increase as these cells reached M1. By contrast,
there was no significant difference in the level of the p21Waf1-
related CdkI p27Kip1 as the AG05229 cells reached M1 (Fig.
2). The same overall pattern of expression of these CdkIs is
seen in HCA2 cells as they proceed to M1 (Fig. 2).
Abrogation of p53 function extends the cellular life
span of WS fibroblasts
Presenescent AG05229 fibroblasts at 20 PDs (BrdU LI of
3.4±0.8%) were infected with amphotropic retroviral vectors
encoding a neomycin resistance gene (neoR) alone (Wyllie
et al., 1993) or with HPV16 E6 (Halbert et al., 1991).
Analysis of G418-resistant colonies (designated 5229.neo
and 5229.E6) began two to three weeks after infection.
As expected, cells expressing neoR alone ceased
proliferating during the first two weeks and entered
replicative senescence, forming clones of up to 5 PDs (32
cells) (Fig. 3B). The 5229.neo cells at this stage were
essentially identical to uninfected AG05229 cells at M1 (not
shown). By contrast, expression of HPV16 E6 resulted in
evasion of senescence and generated rapidly growing
colonies as observed visually (Fig. 3, Fig. 4A). As the
5229.E6 colonies grew, they consistently went through a brief
phase of cell death coupled with continued colony expansion
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Fig. 2. Immunoblot analysis of AG05229 and HCA2 fibroblasts
with or without the expression of HPV16 E6. Lysates were
prepared from cycling cells (young), senescent cells (M1), cycling
E6-infected cells (CyE6) and E6-infected cells at Mint (Mint) for
both AG05229 and HCA2. Expression levels were compared for
various cell-cycle components as indicated. Approximately equal
amounts of cell lysate protein (23 m g top, 19 m g middle and 11 m g
bottom panels, respectively) were loaded per lane as verified by
India-ink staining; the HCA2 cells at CyE6 lane in the bottom
panel is slightly overloaded. Molecular mass markers (M) are
shown in kDa. The hyperphosphorylated forms of pRb are denoted
by the small arrows.
Fig. 3. Extension of
cellular lifespan of Werner-
syndrome fibroblasts
following abrogation of
p53 function by HPV E6.
(A) Growth curve of total
cell number versus time for
E6-infected AG05229
clone 6. (B) Comparison of
growth levels achieved for
control (C-1 to C-6) and
E6-infected (E6-1 to E6-
11) AG05229 clones. E6-
p30 is a pooled sample of
30 G418-resistant colonies.
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(Fig. 3A). Eventually, >80 days post-infection, net growth
ceased and the cells entered a state similar to the second
senescence-like state, which we have termed Mint in HCA2.E6
fibroblasts (Bond et al., 1999). The presence of cell death
makes the absolute determination of lifespan extension in the
5229.E6 colonies problematical. However, the Mint-like state
was reached with a final cell count equivalent to 15-25 PDs
post-infection (10-20 PDs beyond M1; Fig. 3B). A pooled
sample of 30 colonies (5229.E6p30) arrested in a Mint-like
state after 21.5 PDs post-infection (Fig. 3B), but a crisis-like
phase was not obvious, possibly owing to the mixed population
of clones of differing lifespans.
The young 5229.E6 cells (<13 PDs post-infection) were
small (Fig. 4A), showed a high BrdU LI (25.2±1.8%), a low
SAb -gal index (3.5±0.8%) (Fig. 4C) and a TUNEL index of
<1%, indicating that there was no significant cell death
occurring (Fig. 4D).
The WS cells at Mint were very large and highly irregular in
morphology (Fig. 4E), with a low BrdU LI (1.8±0.6%) and a
high SA b -gal index (92.6±1.2%) (Fig. 4G). FACS analysis
showed a significant proportion (~8%) of Mint cells with >4N
DNA content, indicating the presence of polyploid cells (not
shown). An inspection of 5229.E6 cells fixed on coverslips
revealed that 9±1.3% of the Mint cells had more than two nuclei
(Fig. 4F). Lower-power inspection of the culture revealed a
low, but significant, level of phase-bright cells that probably
represent mitoses (not shown), and there was a build up of cell
debris in the culture medium, suggesting the occurrence of cell
death. TUNEL analysis showed 5±1.0% positive nuclei (Fig.
4H), suggesting that some of this cell death was due to
apoptosis. However, overall cell number was stable (with
occasional refeeding) in this state for several weeks.
Expression of cell-cycle proteins in normal and WS
fibroblasts
Cycling AG05229 cells showed moderate levels of p21Waf1 in
22.5%±1.8% of the nuclei by immunocytochemistry, which
increased to 91.2%±1.3% of the nuclei by the time the cells
reached M1. Expression of HPV16 E6 caused a dramatic
decrease in both the intensity and proportion of nuclei positive
for p21Waf1, with only 2.5±0.7% of nuclei showing detectable
immunostaining at 20 days (Fig. 4B). The cells at this time had
undergone ~13 PDs since infection and were growing rapidly.
This was followed by a slow increase in the number of
immunopositive nuclei, reaching 15±1.6% by Mint (Fig. 4F).
Immunoblot analysis using anti-p21Waf1 antibodies
confirmed the immunocytochemistry data (Fig. 2). (The
reasons for the apparently similar levels of p21Waf1 protein in
cycling and M1 AG05229 cells are outlined above.) In control
HCA2 fibroblasts, the level of p21Waf1 was low in cycling cells
and high in senescent cells (Fig. 2). When E6 was introduced
into the cells, the level of p21Waf1 was reduced to almost
undetectable levels, although they rose slightly as the cells
entered the Mint, for both 5229.E6 and HCA2.E6 cells (Fig. 2).
p53 was readily detectable in AG05229 and HCA2 cells in
both cycling cells and at M1 (Fig. 2). In the E6-infected cells,
however, p53 protein was barely detectable, confirming E6-
mediated degradation of p53 (Fig. 2). These data, taken
together, indicate that p21Waf1 is upregulated at M1 and that
abrogation of p53 using E6 results in a low level of expression
of p21Waf1 for both AG05229 and HCA2 cells.
The level of the CdkI p16Ink4a is reported to increase in
HCA2 cells when they reach M1 (Bond et al., 1999). This
increases further in E6-infected HCA2 cells as they reach Mint
(Bond et al., 1999) (Fig. 2), suggesting that increased p16Ink4a
production might compensate for the lack of p21Waf1
production in cell-cycle arrest. An increase in p16Ink4a was
seen in WS cells as they reached M1, but no further increase
was found as 5229.E6 cells reached Mint (Fig. 2).
Densitometric analysis indicated that the low level of p16Ink4a
seen at Mint was not due to different protein loading. In fact,
the level of p16Ink4a might actually have decreased in these
cells after E6 production, although the level increased again as
the cells reached Mint without reaching the level seen at M1.
The CdkI p27Kip1 has been reported to be elevated in
senescent human fibroblasts (Bringold and Serrano, 2000).
Thus we probed the western blot with anti-p27Kip1 antibodies
Fig. 4. Immunocytochemical
analysis of E6-expressing
AG05229 cells.
(A-D) Cycling E6-infected
cells. (E-H) E6-infected cells
at Mint. The assays are:
PC, phase contrast;
p21, immunocytochemical
detection of p21Waf1; SAb gal,
histochemical assessment of
SAb -gal activity; TUNEL,
assay for apoptosis. Arrows
indicate multinucleate cells
(F) and apoptotic cells (H).
All cells except PC are
counterstained with
haematoxylin. Cell-based
assays were done in triplicate.
White bar, 100 m m (A,E);
black bar, 100 m m (B-D,F-H).
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and found no obvious changes in the levels of p27Kip1 in any
of the WS or HCA2 samples in this study (Fig. 2).
The presence of cycling cells in some of these populations
was indicated by probing the western blots with an anti-pRb
antibody that detects both hyper- and hypophosphorylated
forms of pRb; the hypophosphorylated form of pRb is growth
inhibitory (Stein et al., 1990). In all the cycling populations, a
doublet was detected (indicated by the arrows), which was not
seen in any of the four noncycling populations (Fig. 2). As
noted above, the upper hyperphosphorylated band was present
at a reduced level in cycling WS cells.
Senescent WS fibroblasts undergo DNA synthesis after
injection of a p53-neutralizing antibody
The lifespan extension of WS cells following production of
HPV16 E6 is consistent with a p53-dependent cell-cycle arrest.
However, because of the many non-p53 targets of E6, we
wished to provide an independent method of abrogating p53
function in WS AG05229 cells. The anti-p53 antibody DO-1
recognizes an epitope within the N terminus of p53 (amino
acids 20-25) (Stephen et al., 1995; Böttger et al., 1996) that
includes key residues required for transactivation (amino acids
22 and 23) (Lin et al., 1995). Previous work has shown that
microinjection of DO-1 antibodies into senescent HCA2 cells
effectively abrogates p53 activity and allows the cells to re-
enter the cell cycle (Gire and Wynford-Thomas, 1998).
Thus, DO-1 antibodies were introduced by microinjection
into senescent AG05229 cells (BrdU LI of 1.8±0.6%). 48 hours
after injection, 13/68 (19.1±4%) of the DO-1-injected cells
were synthesising DNA as assessed by a 4-hour BrdU pulse,
compared with 0/30 (0%) of cells injected with the control
antibodies (Fig. 5). Thus, antibody abrogation of p53 function
results in these cells re-entering the cell cycle and provides
confirmation that M1 arrest in WS cells is a p53-dependent
process.
Spontaneous escape from Mint in WS fibroblasts
Pooled 5229.E6p30 cells at Mint were maintained with regular
refeeding for several weeks without net gain or loss in cell
number (Fig. 6A). They had a low BrdU LI (1.8±0.6%) and
a high SA b -gal index (>90%) throughout this period of
stationary growth (not shown). Visual inspection revealed a
low level of mitotic cells (Fig. 6B), that most cells had a large,
irregular morphology and that there was a gradual build up of
cellular debris.
Interestingly, however, ~150 days after the onset of the Mint-
like state (257 days post-infection), the culture began to expand
rapidly (Fig. 6A). Most cells at this time were small with
similar morphology to uninfected growing cells, although
there was a significant proportion of Mint-like cells and
many mitoses were present (Fig. 6C). The cells had a high
BrdU LI (39.6±2.2%) and a low SA b -gal index (2.2±0.65%)
at a PD level of 26.2 (i.e. ~5 PDs beyond the Mint-like state)
(not shown). After more than 280 days post-infection, the
population began to decrease in total cell number, coincident
with a marked increase in the levels of cell death. This
behaviour resembled a crisis state, with the cells having an
apoptotic index of 5±1% as assayed by TUNEL analysis (not
shown). The cells at this stage were very irregular in
morphology and apoptotic-like cells could be seen clearly (Fig.
6D). After 410 days post-infection, all the cells of the
5229.E6p30 culture had died.
Mint in WS fibroblasts is a telomere-dependent, p53-
independent event
WS fibroblasts can bypass the M1 senescent state and be
immortalized by the ectopic production of the human
telomerase catalytic subunit hTERT (Ouellette et al., 2000;
Wyllie et al., 2000), indicating that M1 is telomere driven. To
investigate whether Mint is also a telomere-driven event, we
produced telomerase in post-M1 5229.E6 cells. Late-passage
5229.E6 cells were infected with amphotropic viruses
expressing either the puromycin resistance gene alone or the
puromycin resistance and hTERT genes. The cells used were
5229.E6 clone 6 at a PD level of 20.5 (post-infection), which
are beyond M1 but still distant from Mint, which occurs at ~25
PDs in this clone.
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Fig. 5. Microinjection of control IgG or anti-p53 antibodies into
senescent AG05229 cells. The injected cells are marked by Texas
Red, nuclei are detected by DAPI staining and BrdU incorporation is
marked by FITC. The images are merged in the bottom panels. The
DO-1-injected cells show two nuclei incorporating BrdU. Bar,
100 m m.
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Analysis of puromycin-resistant colonies (designated
5229.E6.puro and 5229.E6.hTERT) was begun 4-5 weeks after
infection. The 5229.E6.puro clones reached a stationary phase
resembling Mint after 49 days (BrdU LI of 3.8±0.85% and
SAb -gal index of 91±1.3%) at ~9 PDs post-infection, and no
expansion in cell numbers was seen over a further 56 days (Fig.
7A,B). Conversely, both of the two 5229.E6.hTERT clones
continued expanding and have now reached a total of 33 and
44 PDs post-infection and are still growing (Fig. 7A,B). These
cells were small (Fig. 7C) and had growth characteristics
similar to young AG05229 cells (BrdU LI of 23.4±1.9%,
p21Waf1 labelling of 1.6±0.6%, SA b -gal index of 3.4±0.8%,
TUNEL level of <1%; data not shown). Thus, it appears that
ectopic expression of hTERT is sufficient for post-M1 E6-
infected AG05229 fibroblasts to avoid Mint, suggesting that
Mint is a p53-independent proliferative lifespan barrier that
requires telomere erosion.
Discussion
WS AG05229 fibroblasts in culture undergo senescence
after a reduced replicative lifespan compared with normal
dermal fibroblasts. At M1, most cells (>77%) have a 2N
DNA content, suggestive of a G1-S arrest, but a significant
proportion (~20%) have a higher DNA content indicative
of either G1 tetraploid cells or G2-M arrest. The presence
of significant numbers of G1 tetraploid cells at M1 has
been reported for IMR90 cells by karyotype analysis of
metaphase cells (Sherwood et al., 1988), suggesting that
AG05229 cells with a G2-M DNA content are also G1
tetraploids. WS cells at M1 resemble senescent normal
cells in morphology, BrdU LI, SA b -gal activity and a low
level of cell death (Bond et al., 1999; Dulic et al., 2000).
Similarly, they have elevated levels of the Cdk inhibitors
p21Waf1 and p16Ink4a, and abrogation of p53 by
microinjection of anti-p53 antibodies into senescent cells
allowed them to re-enter the cell cycle. These data, together
with the observation that ectopic expression of telomerase
allows WS cells to avoid M1 (Ouellette et al., 2000; Wyllie et
al., 2000; Choi et al., 2001), are consistent with senescence in
WS cells being a telomere-driven p53-dependent event, and
suggest that M1 in WS cells is essentially identical to M1 in
normal fibroblasts (Gire and Wynford-Thomas, 1998; Bond et
al., 1999; Dulic et al., 2000).
Expression of HPV16 E6 causes WS cells to bypass M1 and
to continue growth until reaching a second proliferative
lifespan barrier, Mint, after a similar number of PDs to
HCA2.E6 cells (Bond et al., 1999). Most WS.E6 cells at Mint
resemble normal Mint fibroblasts in that they are very large and
have a low level of BrdU incorporation and high SA b -gal
activity. In E6-infected WS cells, the level of p21Waf1 is much
Fig. 6. Growth characteristics of 5229.E6p30 cells that escape
Mint. (A) Growth kinetics. (B-D) Phase contrast images showing
the cells at 250 days (B), 270 days (C) and 350 days (D) post-
infection. Arrows indicate mitotic cells (B,C) and apoptotic-like
cells (D). Bar, 100 m m.
Fig. 7. Growth characteristics of 5229.E6 cells infected with hTERT. (A) Growth curve of population doublings achieved against time:
d, E6.hTERT clone 2; s, E6.hTERT clone 3; j, growth of the control clones (only clone 2 shown for clarity). (B) The same data as
represented by a histogram. C-1 to C-3 are the control clones and hTERT-1 and hTERT-2 are the hTERT-infected clones. (C) Phase-contrast
image showing the morphology of the E6.hTERT cells. Bar, 100 m m.
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reduced and only rises slightly as the cells reach Mint. Similar
changes in p21Waf1 are also seen in HCA2.E6 and IMR90.E6
cells (Bond et al., 1999; Dulic et al., 2000). This is correlated
with the reduced levels of p53 found in these cells. Together
with data indicating that loss of p21Waf1 production is sufficient
for normal fibroblasts to bypass senescence (Brown et al.,
1997), it seems probable that this reduction in p21Waf1 levels is
causal in permitting WS cells to bypass M1.
In contrast to HCA2 cells, however, the level of p16Ink4a is
reduced in E6-infected WS cells and, although it rises slightly
at Mint, it is still at a level below that found at M1. This is
similar to the changes in p16Ink4a found in IMR90 cells (Dulic
et al., 2000). These differences in Cdk inhibitors at Mint
probably reflect differences between fibroblast strains isolated
from different donors and from different tissues. Similarly,
although the Mint state in WS cells differs from that reported
in HCA2 cells (Bond et al., 1999) by the presence of continued
cell turnover (with mitotic events being balanced by cell death),
it is similar to that reported in other normal cell strains (e.g.,
IMR90 cells) (Dulic et al., 2000).
We have observed one example of spontaneous escape from
Mint, in which, ~150 days after entry into Mint, a WS.E6 culture
began to expand rapidly. After an extended period, this culture
underwent a crisis during which the cells died, a situation
comparable to that previously reported in normal LF1 cells
(Brown et al., 1997). This situation has not been reported for
HCA2 cells (Bond et al., 1999); however, Filatov et al. (Filatov
et al., 1998) found that E6-infected F5 neonatal foreskin
fibroblasts did not proceed to a Mint-like state and had few
SAb -gal-producing cells. Instead these cells entered a crisis
during which telomerase expression was induced and,
thereafter, population expansion was continuous. Ectopic
production of hTERT in WS.E6 fibroblasts appears to be
equally permissive for continuous expansion.
It remains to speculate about the mechanism of the cell-cycle
arrest observed at Mint in human fibroblasts. In HCA2 cells,
the arrest might be due to the large increase in p16Ink4a, because
it has been shown that p16Ink4a induction in young and
immortalized human fibroblasts can restore growth arrest
(McConnell et al., 1998; Vogt et al., 1998). This is unlikely to
be the situation in WS cells, because the level of p16Ink4a does
not increase. Alternatively, the arrest might be due to the small
increase in p21Waf1 levels, as has been suggested for IMR90
cells (Dulic et al., 2000). A final possibility is that there is a
mechanism that links the erosion of telomeres to cell-cycle
arrest that is independent of p53, but whose nature remains
obscure (Bond et al., 1999).
Cellular senescence in human fibroblasts appears to be
triggered by telomere erosion (Allsop and Harley, 1995;
Bodnar et al., 1998; Vaziri and Benchimol, 1998; Wright and
Shay, 2002). WS fibroblasts exit the cell cycle at a higher rate
than normal fibroblasts and so senesce more rapidly (Faragher
et al., 1993), and it appears that their telomeres erode at a
greater rate (Schulz et al., 1996), although this is equivocal.
Young WS fibroblasts have telomeres of similar length to
young normal cells but they senesce with longer mean telomere
lengths (Schulz et al., 1996). This might indicate that WS cells
are more sensitive to variations in telomere length. However,
the telomere length measured by Schulz et al. (Schulz et al.,
1996) is a mean length and the presence of a subset of much
smaller telomeres in the senescent WS cells is not excluded.
More work to resolve this issue is clearly indicated in the
future. The longer mean telomere length at senescence might
explain the observation that WS.E6 cells make a similar
number of PDs as HCA2.E6 cells before the onset of Mint,
despite the increased rate of erosion. The presence of telomere-
driven senescence in WS cells (Ouellette et al., 2000; Wyllie
et al., 2000; Choi et al., 2001) and the similarities in the
signalling response (this study), would argue for a defect that
manifests itself early in the signalling pathway, perhaps by
modulating the rate of telomere erosion in WS cells. Thus, a
role for WRNp in telomere dynamics is strongly implicated.
The conclusions to be drawn from this work are that WS
fibroblasts behave in a way that is similar to normal fibroblasts
and that, despite having a much reduced in vitro lifespan, the
transducing pathways leading to senescence in WS cells are
essentially the same. Thus, the study of premature ageing in
WS patients (presumably resulting from this premature
replicative senescence) is likely also to reflect the effects of
cellular ageing in normal individuals, thus making WS a
suitable model for some aspects of the ageing process. This
model, in which the loss of WRNp expression is linked to
whole body ageing via accelerated replicative senescence, does
not exclude other aspects of the WS cellular phenotype
contributing to the clinical spectrum of WS; one could readily
postulate a link between chromosome instability and the
observed increase in mesenchymal cancers in WS (Salk, 1982;
Goto et al., 1996). WS is a complex disease and loss of WRNp
expression might well contribute to various aspects in different
ways.
We thank members of our laboratories for their discussions. This
work was supported by the BBSRC’s Science of Ageing Initiative.
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